MedTrace Logo

A Trial of Intravenous Fluids During Labor

NCT01110005 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 318

Last updated 2024-01-19

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if intrapartum use of a glucose-containing solution will improve the outcomes in pregnant women and their babies.

Conditions

  • Ketosis

Interventions

OTHER

D5 Lactated Ringer's Solution (D5LR)

D5LR IV fluid

OTHER

Lactated Ringer's Solution (LR)

LR IV fluid

Sponsors & Collaborators

  • Lehigh Valley Hospital

    collaborator OTHER

  • The Reading Hospital and Medical Center

    collaborator OTHER

  • St. Luke's Hospital, Pennsylvania

    collaborator OTHER

  • Milton S. Hershey Medical Center

    lead OTHER

Principal Investigators

  • Richard S Legro, M.D. · The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, United States

  • John Smulian, M.D. · Lehigh Valley Hospital, Allentown, Pennsylvania, United States

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01110005 on ClinicalTrials.gov